Complement regulatory proteins and autoimmunity
- PMID: 11140463
Complement regulatory proteins and autoimmunity
Abstract
To discriminate self from non-self is an essential issue in the immune system. Autologous cells are protected against complement-mediated cell injury by the self-recognition mechanism using complement regulatory proteins composed of complement receptor type 1 (CR1, CD35), membrane cofactor protein (MCP, CD46), decay accelerating factor (DAF, CD55) and homologous restriction factor (protectin, CD59). Recently, the up-regulation of these molecules has been widely shown in inflammatory tissues and organs affected by autoimmune diseases, and in vitro assays have revealed that immune complexes or several cytokines, including interferongamma, tumor necrosis factor alpha, interleukin 1beta and transforming growth factor beta, can up-regulate these molecules. In contrast, it has been found that expression of these complement regulatory proteins is markedly decreased on autologous cells undergoing apoptosis. These findings suggest that complement regulatory proteins have dual roles at inflammatory sites: enhancement of cellular resistance to complement attack and acceleration of the clearance of cells injurious to the organism due to complement-mediated mechanisms. To assist the former function, a therapeutic approach using recombinant soluble complement regulatory proteins may provide a promising strategy for the treatment of autoimmune diseases.
Similar articles
-
Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.Lymphokine Cytokine Res. 1993 Jun;12(3):167-72. Lymphokine Cytokine Res. 1993. PMID: 7688580
-
Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.Gynecol Oncol. 2000 Feb;76(2):176-82. doi: 10.1006/gyno.1999.5614. Gynecol Oncol. 2000. PMID: 10637067
-
Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.Lab Invest. 1996 Jan;74(1):33-42. Lab Invest. 1996. PMID: 8569195
-
Complement regulatory proteins in glomerular diseases.Kidney Int. 1998 Nov;54(5):1419-28. doi: 10.1046/j.1523-1755.1998.00130.x. Kidney Int. 1998. PMID: 9844117 Review.
-
Immunization against tumor cell surface complement-regulatory proteins.Curr Opin Investig Drugs. 2001 Jul;2(7):959-66. Curr Opin Investig Drugs. 2001. PMID: 11757799 Review.
Cited by
-
CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity.Am J Pathol. 2019 Jul;189(7):1386-1401. doi: 10.1016/j.ajpath.2019.04.008. Epub 2019 May 17. Am J Pathol. 2019. PMID: 31103439 Free PMC article.
-
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.Hepatology. 2008 Feb;47(2):484-92. doi: 10.1002/hep.22063. Hepatology. 2008. PMID: 18220286 Free PMC article.
-
CR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies.Gene Ther. 2009 Oct;16(10):1245-59. doi: 10.1038/gt.2009.77. Epub 2009 Jun 25. Gene Ther. 2009. PMID: 19554032 Free PMC article.
-
Impact of Methylated Cyclodextrin KLEPTOSE® CRYSMEB on Inflammatory Responses in Human In Vitro Models.Int J Mol Sci. 2024 Sep 9;25(17):9748. doi: 10.3390/ijms25179748. Int J Mol Sci. 2024. PMID: 39273695 Free PMC article.
-
Complement regulatory proteins: Candidate biomarkers in differentiating tuberculosis pleural effusion.Front Immunol. 2023 Feb 3;14:1073884. doi: 10.3389/fimmu.2023.1073884. eCollection 2023. Front Immunol. 2023. PMID: 36820087 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous